Goldman Sachs
OFIX icon

Goldman Sachs’s Orthofix Medical OFIX Stock Holding History

Goldman Sachs’s Portfolio OFIX Stock Details OFIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-119,900
Closed -$3.71M – 7259
2014
Q3 		$3.71M Sell
119,900
-265,700
-69% -$8.82M ﹤0.01% 3323
2014
Q2 		$14M Sell
385,600
-155,600
-29% -$5.03M ﹤0.01% 2091
2014
Q1 		$16.3M Buy
541,200
+408,000
+306% +$9.41M 0.01% 1936
2013
Q4 		$3.04M Buy
133,200
+114,000
+594% +$2.38M ﹤0.01% 3617
2013
Q3 		$399K Buy
+19,200
New +$466K ﹤0.01% 5333

Other funds holding OFIX

ECM
Engine Capital Management New York $1.03B AUM 4.33% 1-Year Est. Return
JIC
Juniper Investment Company New York $378M AUM 95.37% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Goldman Sachs's OFIX Position: Q2 2026 in Review

Goldman Sachs increased its Orthofix Medical (OFIX) stake by 38% in Q2 2026, buying an estimated $1.34M and bringing the position to 446,140 shares worth $4.08M. The position accounts for ﹤0.01% of the portfolio, ranked #4064.

Goldman Sachs first reported a position in OFIX in Q2 2013 and has held it in 53 quarters since. The position peaked at $42.8M in Q2 2018. 144 funds tracked by Wall St. Rank hold OFIX as of Q2 2026.

  • Goldman Sachs held 446,140 shares of Orthofix Medical worth $4.08M as of Q2 2026.
  • Goldman Sachs bought 121,715 Orthofix Medical shares in Q2 2026, an estimated $1.34M.
  • Orthofix Medical made up ﹤0.01% of Goldman Sachs's portfolio in Q2 2026, its #4064 holding.
  • Goldman Sachs first reported a position in Orthofix Medical in Q2 2013 and has held it in 53 quarters since.
  • Goldman Sachs's Orthofix Medical position peaked at $42.8M in Q2 2018.
  • 144 funds tracked by Wall St. Rank held Orthofix Medical as of Q2 2026.

Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.